Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.510.09%
QQQ
717.750.17%
BTC/USD
79719.301.9154%
DIA
532.800.24%
GLD
406.310.11%
TLT
82.21-

Aethlon Medical Inc

AEMDNASDAQ
Trade with Public
Trade with Public
$1.82
-0.11-5.7%
At close: Sep 4, 5:00 PM EST
$1.77
-0.05-2.75%
After Hours: 6:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Aethlon Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Aethlon Medical (AEMD).

Price Target Range — 6 Quarters

Analyst Consensus — 1 Analysts

1Hold
Consensus RatingBuy# Analysts1Avg. Consensus PT$4Upside to Avg. PT+140.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 14, 2025HC Wainwright & Co.Swayampakula RamakanthMaintainedNeutral$2
Jul 7, 2025HC Wainwright & Co.Swayampakula RamakanthAssumesNeutral$2
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Neutral on Aethlon Medical, Maintains $1.5 Price Target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Aethlon Medical (NASDAQ:AEMD) with a Neutral and maintains $1.5 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Assumes Aethlon Medical at Neutral, Announces Price Target of $1.5

HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Aethlon Medical (NASDAQ:AEMD) with a Neutral rating and announces Price Target of $1.5.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Aethlon Medical, Maintains $7 Price Target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved